Understanding prostate cancer progression and survival in African American men
Identifying factors associated with prostate cancer progression and survival in African American men: The RESPOND Cohort
This project aims to understand why prostate cancer affects African American men more severely by looking at many different factors.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11143205 on NIH RePORTER |
What this research studies
African American men face a much higher risk of developing and dying from prostate cancer compared to white men, and we don't fully understand why. This project, called RESPOND, is a nationwide effort to gather information from over 12,500 African American men diagnosed with prostate cancer. We are collecting details on their stress levels, environment, treatments, genetics, and tumor characteristics. By following these men over several years, we hope to learn more about what causes the disease to progress and how it affects survival.
Who could benefit from this research
Good fit: This project focuses on African American men who have been diagnosed with prostate cancer.
Not a fit: Patients who are not African American or who do not have prostate cancer would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of prostate cancer in African American men, potentially improving diagnosis, treatment, and outcomes for this community.
How similar studies have performed: While individual factors have been explored, this comprehensive, nationwide cohort approach to understanding multiple interacting factors in African American men with prostate cancer is a significant and relatively novel effort.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Haiman, Christopher Alan — University of Southern California
- Study coordinator: Haiman, Christopher Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.